147 completed. 147 Phase 3, 17 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 147 | Completed 147 |
| Phase 2 | 17 | Completed 17 |
Follow Vomiting: new trials by email Literature Review of Vomiting trials Research Report on Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients Aprepitant 40mg, Placebo - Nausea and Vomiting, Postoperative, Prevention | Phase 3 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 260 | 2026-02-27 | 2026-08-27 |
| Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy Dexamedomedine, Dexamethasone - Postoperative Nausea and Vomiting | Phase 3 | Completed | Patel Hospital, Pakistan | 68 | 2025-06-01 | 2026-02-23 |
| To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. QLM2010 for injection;dexamethasone, fosaprepitant dimeglumine for injection;palonosetron hydrochloride injection;dexamethasone - Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Completed | Qilu Pharmaceutical Co., Ltd. | 665 | 2025-01-03 | 2025-11-18 |
| Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients Aprepitant Injection - Gynecological Tumor, Ovarian Cancer | Phase 3 | Completed | Sichuan Cancer Hospital and Research Institute | 143 | 2024-05-31 | 2025-12-04 |
| NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens Netupitant / Palonosetron Oral Capsule [Akynzeo], Olanzapine, Dexamethasone Oral - Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy | Phase 3 | Completed | Fudan University | 644 | 2024-05-01 | 2026-04-09 |
| Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets - Functional Dyspepsia | Phase 3 | Completed | Abbott | 564 | 2024-02-28 | 2026-04-03 |
| An Evaluation the Effect of Superhydration Versus Dextrose 10% for Prevention of Post Operative Nausea and Vomiting After Laparoscopic Cholecystectomy (Prospective Randomised Controlled Study) ringer lactate (20ml/kg), Dextrose 10% - Postoperative Nausea and Vomiting (PONV) | Phase 3 | Completed | Ain Shams University | 204 | 2024-02-25 | 2025-02-26 |
| Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting Aprepitant Injection, Aprepitant Injection Placebo - Postoperative Nausea and Vomiting | Phase 3 | Completed | Qilu Pharmaceutical (Hainan) Co., Ltd. | 518 | 2024-02-02 | 2025-04-23 |
| The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics Metoclopramide and Vitamin B6, Vitamin B6, Ondansetron - Vomiting | Phase 2 / Phase 3 | Completed | University of Baghdad | 250 | 2024-01-30 | 2024-04-30 |
| Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients Amisulpride Injection, Dexamethasone - Nausea and Vomiting, Postoperative | Phase 2 / Phase 3 | Completed | Acacia Pharma Ltd | 453 | 2024-01-18 | 2025-06-25 |
| Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Completed | Vanda Pharmaceuticals | 17 | 2024-01-09 | 2026-10-19 |
| Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy At-night Dexamethasone, At-induction Dexamethasone - Postoperative Nausea and Vomiting, Postoperative Pain | Phase 2 / Phase 3 | Completed | Mansoura University | 60 | 2023-10-08 | 2024-01-25 |
| Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy normal Saline, Dexamethasone, Dexmedetomidine - Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting | Phase 3 | Completed | Al-Azhar University | 120 | 2023-08-10 | 2025-06-18 |
| Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization | Phase 3 | Completed | Jennifer Holder-Murray | 3395 | 2023-05-15 | 2026-05-28 |
| Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV 5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone - Chemotherapy-induced Nausea and Vomiting | Phase 3 | Completed | Xingchen Peng | 275 | 2023-04-15 | 2025-06-04 |
| Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding Metoclopramide, Placebo - Upper Gastrointestinal Bleeding | Phase 3 | Completed | Universidad Autonoma de Nuevo Leon | 50 | 2023-03-01 | 2024-10-09 |
| Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy Ondansetron 8mg, Gabapentin - Post Operative Nausea and Vomiting, Sleeve Gastrectomy | Phase 3 | Completed | Tanta University | 100 | 2022-10-01 | 2025-04-17 |
| THRIVE Feasibility Trial Anesthetic technique Propofol TIVA, Anesthetic technique inhaled agent - Surgery--Complications, Anesthesia Complication | Phase 3 | Completed | Washington University School of Medicine | 300 | 2022-09-29 | 2023-11-24 |
| Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery Baclofen Tablets - Postoperative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy | Phase 2 / Phase 3 | Completed | Tanta University | 100 | 2022-08-22 | 2025-04-22 |
| Postoperative Analgesic Effectiveness of Bupivacaine With and Without Dexmedetomidine in Patients With Abdominal Surgery bupivacaine wound infilteration, Bupivacaine plus dexmedetomidine wound infilteration - Post Operative Pain, Bradycardia | Phase 2 / Phase 3 | Completed | Sahiwal medical college sahiwal | 64 | 2022-02-20 | 2024-08-01 |
Showing 20 of 147. Sign in to see all of them.
Nausea (62) · Postoperative Nausea and Vomiting (48) · Pain, Postoperative (10) · Pain (9) · Breast Neoplasms (6) · Neoplasms (6) · Diarrhea (5) · Gastroparesis (5) · Abdominal Pain (4) · Uterine Cervical Neoplasms (4) · Fever (3) · Gastroenteritis (3) · Hyperemesis Gravidarum (3) · Hypotension (3)
Pathological Conditions, Signs and Symptoms (147) · Signs and Symptoms (147) · Signs and Symptoms, Digestive (146) · Pathologic Processes (54) · Postoperative Complications (50) · Nausea (42) · Neurologic Manifestations (26) · Neoplasms (19) · Neoplasms by Site (19) · Digestive System Diseases (16) · Gastrointestinal Diseases (15) · Pain (14) · Female Urogenital Diseases and Pregnancy Complications (8) · Urogenital Diseases (8)
Dexamethasone (47) · Ondansetron (31) · Aprepitant (23) · Palonosetron (21) · Granisetron (17) · Olanzapine (11) · Calcium Dobesilate (9) · fosaprepitant (6) · Gabapentin (5) · Metoclopramide (5) · Sodium Chloride (5) · casopitant (5) · netupitant, palosentron drug combination (5) · Saline Solution (4) · Acetaminophen (3)
Merck Sharp & Dohme LLC (11) · Helsinn Healthcare SA (9) · Acacia Pharma Ltd (6) · GlaxoSmithKline (5) · M.D. Anderson Cancer Center (4) · Alliance for Clinical Trials in Oncology (3) · Charleston Laboratories, Inc (3) · Tesaro, Inc. (3) · All India Institute of Medical Sciences (2) · Evoke Pharma (2) · Gary Morrow (2) · Heron Therapeutics (2) · Instituto Mexicano del Seguro Social (2) · NCIC Clinical Trials Group (2) · Odense University Hospital (2)
United States (52) · Germany (18) · China (14) · Canada (13) · France (13) · Hungary (10) · Russia (10) · Czechia (9) · Egypt (9) · Italy (9) · Poland (9) · Bulgaria (8) · Ukraine (8) · India (7) · Argentina (6)
Dennis Vargo, MD (3) · Alejandro Gonzalez-Ojeda, M.D., Ph.D. (2) · A. Riaz, MD (1) · Aldo Maina, M.D. (1) · Alex Molassiotis, MD (1) · Alex Sia (1) · Alexander Binning, M.D. (1) · Amal I. Melhem-Bertrandt, MD (1) · Andrea Bezjak, MD, MSC, FRCPC (1) · Arne Johan Norheim, MD Doctor phD (1) · Auro del Giglio, phD (1)
PMID 19775450, PMID 23062719, PMID 24276953, PMID 26272769, PMID 27410922, PMID 28285236, PMID 30968588, PMID 11030465, PMID 11773155, PMID 12145072, PMID 12377323, PMID 12562658, PMID 12736106, PMID 15680647, PMID 16198982, PMID 16436839, PMID 16849762, PMID 19135415, PMID 19428297, PMID 19568773, PMID 19805683, PMID 20692030, PMID 20692031, PMID 20835873, PMID 20843504, PMID 21182781, PMID 21383291, PMID 21436683, PMID 21465325, PMID 21851346, PMID 21872708, PMID 22024310, PMID 22141732, PMID 22286518, PMID 22546966, PMID 22915657, PMID 22972538, PMID 23041302, PMID 23244208, PMID 23510951, PMID 23598819, PMID 23811424, PMID 23887247, PMID 24015953, PMID 24438599, PMID 24684734, PMID 24882606, PMID 24911369, PMID 25037960, PMID 25052410
2014 (2), U10CA037420 (2), 2005 (1), 2009 (1), 2019 (1), U10CA031946 (1)